Top Industry News
- FDA Releases Guidance on Labeling of Drug Use-Related Software Outputs
- Swissmedic Updates Guidance on Temporary Medicine Authorization to Harmonize Deadlines
- FDA Will Continue to Use Remote Inspection Tools to Assess Pending Applications
- IMDRF Guidance Updates Thinking on Personalized Medical Devices
- FDA Regulatory Considerations for Prescription Drug Use-Related Software
- Canadian Food Inspection Agency(CFIA) Announces Nationwide Recall of 29 Energy Drink Brands.
- ANVISA New Topics for SaMD Software Regularization
- Medical Devices: EU Regulations for MDR and IVDR (Northern Ireland)
- SFDA Product Recall Guidance
- FDA Issues Draft Guidance Regarding Confirmatory Evidence of Clinical Trials
- Notify the MHRA About a Clinical Investigation for a Medical Device
- FDA’s IT Strategy Will Focus on Modernization, AI
- The Hong Kong Special Administrative Region (SAR) Government has Extended the Deadline for Submitting Comments on WTO Notification G/SPS/N/HKG/48.
- FDA Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health Emergencies
- Warning Notice for Intake Mandatory for Certain Ingredients for HFF in South Korea
- Denmark | Concealed Formaldehyde in Cosmetics May Lead to Allergic Reactions
- The EU Takes Action Against Greenwashing and Aims to Enhance Consumer Information Regarding Product Longevity
- California Takes Steps Toward Prohibiting Harmful 'Persistent Chemicals' in Cleaning Products.
Mergers & Acquisitions
- How Well-Staffed Teams Elevate Regulatory Submissions
- How CTIS is Changing the Landscape of Clinical Trials?
- Real-Time Challenges of Converting Legacy Data to New Regulatory Submission Formats
- Streamlining Artwork Processes with Modern Artwork Management Systems
- Optimizing Pharmaceutical Labeling: The Crucial Role of Artwork Flow
- Pediatric Drug Labeling Requirements in the EU and US - A Comparative Analysis